December 22, 2025 · Form 4 insider transaction
Newman Michael James bought 52,204 shares of Indaptus Therapeutics, Inc. at $2.03 per share, a transaction worth $106.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
The Reporting Person acquired 52,204 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025.